Upgrade your portfolio! C3.ai is a strong buy with explosive growth, top-tier partnerships, and AI exposure at a discount.

The company's customer wins this year suggest more revenue expansion to come. In fact, C3.ai forecasts fiscal 2026 sales to ...

The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals' Empaveli (pegcetacoplan) as the first treatment ...

Pegcetacoplan inhibits C3 activation by binding to C3 and its activation fragment C3b, thereby reducing C3 glomerular fragment deposition in patients with C3G and primary IC-MPGN.

This has led to strong growth for the company, with C3.ai's revenue rising 25% year over year in fourth-quarter fiscal year 2025 (ending April 30). It also expects strong growth for FY 2026, with ...

Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...

We've waited quite some time for a reasonable choice of affordable small electric cars, and while they’re not exactly coming ...

C3 Bullion, a pioneer in next-generation gold investment solutions, has launched its India operations, bringing its flagship ...

C3.ai has the ingredients to build a sustainable enterprise AI business. There are risks that could derail C3.ai's expansion. McKinsey estimates that AI could generate up to $4.4 trillion in ...

Police and paramedics were called to the coastbound carriageway of the A299 near Herne Bay at about 10am. The force says four ...

A motorcyclist in his 60s has died in a crash on a main road in east Kent, police have said. The crash happened on the A299 ...

Developer Howard Saffan and concert promoter Jim Koplik helped establish the music event in 2021 and are not ready to say ...